List of Tables
    Table 1. Organ Transplant Immunosuppreant Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Organ Transplant Immunosuppreant Market Trends
    Table 3. Organ Transplant Immunosuppreant Market Drivers
    Table 4. Organ Transplant Immunosuppreant Market Challenges
    Table 5. Organ Transplant Immunosuppreant Market Restraints
    Table 6. Global Organ Transplant Immunosuppreant Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Organ Transplant Immunosuppreant Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Organ Transplant Immunosuppreant Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Organ Transplant Immunosuppreant Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Organ Transplant Immunosuppreant Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Organ Transplant Immunosuppreant Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Organ Transplant Immunosuppreant Revenue Share by Player, 2017-2022
    Table 13. Global Organ Transplant Immunosuppreant Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Organ Transplant Immunosuppreant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organ Transplant Immunosuppreant as of 2021)
    Table 15. Top Players of Organ Transplant Immunosuppreant in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Organ Transplant Immunosuppreant Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Organ Transplant Immunosuppreant Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Organ Transplant Immunosuppreant Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Organ Transplant Immunosuppreant Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Organ Transplant Immunosuppreant Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Organ Transplant Immunosuppreant Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Organ Transplant Immunosuppreant Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Organ Transplant Immunosuppreant Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Organ Transplant Immunosuppreant Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Organ Transplant Immunosuppreant Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Organ Transplant Immunosuppreant Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Organ Transplant Immunosuppreant Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Astellas Pharma Company Details
    Table 31. Astellas Pharma Business Overview
    Table 32. Astellas Pharma Organ Transplant Immunosuppreant Product
    Table 33. Astellas Pharma Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million)
    Table 34. Astellas Pharma Recent Development
    Table 35. Roche Company Details
    Table 36. Roche Business Overview
    Table 37. Roche Organ Transplant Immunosuppreant Product
    Table 38. Roche Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million)
    Table 39. Roche Recent Development
    Table 40. Novartis Company Details
    Table 41. Novartis Business Overview
    Table 42. Novartis Organ Transplant Immunosuppreant Product
    Table 43. Novartis Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million)
    Table 44. Novartis Recent Development
    Table 45. Pfizer Company Details
    Table 46. Pfizer Business Overview
    Table 47. Pfizer Organ Transplant Immunosuppreant Product
    Table 48. Pfizer Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million)
    Table 49. Pfizer Recent Development
    Table 50. GlaxoSmithKline Company Details
    Table 51. GlaxoSmithKline Business Overview
    Table 52. GlaxoSmithKline Organ Transplant Immunosuppreant Product
    Table 53. GlaxoSmithKline Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million)
    Table 54. GlaxoSmithKline Recent Development
    Table 55. Sanofi Genzyme Company Details
    Table 56. Sanofi Genzyme Business Overview
    Table 57. Sanofi Genzyme Organ Transplant Immunosuppreant Product
    Table 58. Sanofi Genzyme Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million)
    Table 59. Sanofi Genzyme Recent Development
    Table 60. Huadong Pharmaceutical Company Details
    Table 61. Huadong Pharmaceutical Business Overview
    Table 62. Huadong Pharmaceutical Organ Transplant Immunosuppreant Product
    Table 63. Huadong Pharmaceutical Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million)
    Table 64. Huadong Pharmaceutical Recent Development
    Table 65. North China Pharmaceutical Huasheng Co. Company Details
    Table 66. North China Pharmaceutical Huasheng Co. Business Overview
    Table 67. North China Pharmaceutical Huasheng Co. Organ Transplant Immunosuppreant Product
    Table 68. North China Pharmaceutical Huasheng Co. Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million)
    Table 69. North China Pharmaceutical Huasheng Co. Recent Development
    Table 70. Hisun Company Details
    Table 71. Hisun Business Overview
    Table 72. Hisun Organ Transplant Immunosuppreant Product
    Table 73. Hisun Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million)
    Table 74. Hisun Recent Development
    Table 75. SL PHARM Company Details
    Table 76. SL PHARM Business Overview
    Table 77. SL PHARM Organ Transplant Immunosuppreant Product
    Table 78. SL PHARM Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million)
    Table 79. SL PHARM Recent Development
    Table 80. Nanjing Hicin Company Details
    Table 81. Nanjing Hicin Business Overview
    Table 82. Nanjing Hicin Organ Transplant Immunosuppreant Product
    Table 83. Nanjing Hicin Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million)
    Table 84. Nanjing Hicin Recent Development
    Table 85. Hongsheng Company Details
    Table 86. Hongsheng Business Overview
    Table 87. Hongsheng Organ Transplant Immunosuppreant Product
    Table 88. Hongsheng Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million)
    Table 89. Hongsheng Recent Development
    Table 90. CINKATE CORPORATION Company Details
    Table 91. CINKATE CORPORATION Business Overview
    Table 92. CINKATE CORPORATION Organ Transplant Immunosuppreant Product
    Table 93. CINKATE CORPORATION Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million)
    Table 94. CINKATE CORPORATION Recent Development
    Table 95. Huitian Company Details
    Table 96. Huitian Business Overview
    Table 97. Huitian Organ Transplant Immunosuppreant Product
    Table 98. Huitian Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million)
    Table 99. Huitian Recent Development
    Table 100. Sinopharm ChuanKang Pharmaceutical Company Details
    Table 101. Sinopharm ChuanKang Pharmaceutical Business Overview
    Table 102. Sinopharm ChuanKang Pharmaceutical Organ Transplant Immunosuppreant Product
    Table 103. Sinopharm ChuanKang Pharmaceutical Revenue in Organ Transplant Immunosuppreant Business (2017-2022) & (US$ Million)
    Table 104. Sinopharm ChuanKang Pharmaceutical Recent Development
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Organ Transplant Immunosuppreant Product Picture
    Figure 2. Global Organ Transplant Immunosuppreant Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Organ Transplant Immunosuppreant Market Size 2017-2028 (US$ Million)
    Figure 4. United States Organ Transplant Immunosuppreant Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Organ Transplant Immunosuppreant Market Size 2017-2028 (US$ Million)
    Figure 6. United States Organ Transplant Immunosuppreant Market Share in Global 2017-2028
    Figure 7. Organ Transplant Immunosuppreant Report Years Considered
    Figure 8. Product Picture of Selective Inhibitor of Cytokine Production And Function
    Figure 9. Product Picture of Immunosuppressive Antimetabolites
    Figure 10. Product Picture of Immunosuppressive Antibodies
    Figure 11. Product Picture of Immunosuppressive Adrenocorticosteroids
    Figure 12. Global Organ Transplant Immunosuppreant Market Share by Type in 2022 & 2028
    Figure 13. Global Organ Transplant Immunosuppreant Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Organ Transplant Immunosuppreant Market Share by Type (2017-2028)
    Figure 15. United States Organ Transplant Immunosuppreant Market Share by Type in 2022 & 2028
    Figure 16. United States Organ Transplant Immunosuppreant Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Organ Transplant Immunosuppreant Market Share by Type (2017-2028)
    Figure 18. Product Picture of Kidney Transplantation
    Figure 19. Product Picture of Liver Transplantation
    Figure 20. Product Picture of Heart Transplantation
    Figure 21. Product Picture of Lung Transplantation
    Figure 22. Product Picture of Pancreas Transplantation
    Figure 23. Global Organ Transplant Immunosuppreant Market Share by Application in 2022 & 2028
    Figure 24. Global Organ Transplant Immunosuppreant Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Organ Transplant Immunosuppreant Market Share by Application (2017-2028)
    Figure 26. United States Organ Transplant Immunosuppreant Market Share by Application in 2022 & 2028
    Figure 27. United States Organ Transplant Immunosuppreant Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Organ Transplant Immunosuppreant Market Share by Application (2017-2028)
    Figure 29. North America Organ Transplant Immunosuppreant Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Organ Transplant Immunosuppreant Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Organ Transplant Immunosuppreant Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America Organ Transplant Immunosuppreant Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Organ Transplant Immunosuppreant Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. UAE Organ Transplant Immunosuppreant Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Astellas Pharma Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2017-2022)
    Figure 58. Roche Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2017-2022)
    Figure 60. Pfizer Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2017-2022)
    Figure 61. GlaxoSmithKline Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2017-2022)
    Figure 62. Sanofi Genzyme Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2017-2022)
    Figure 63. Huadong Pharmaceutical Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2017-2022)
    Figure 64. North China Pharmaceutical Huasheng Co. Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2017-2022)
    Figure 65. Hisun Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2017-2022)
    Figure 66. SL PHARM Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2017-2022)
    Figure 67. Nanjing Hicin Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2017-2022)
    Figure 68. Hongsheng Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2017-2022)
    Figure 69. CINKATE CORPORATION Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2017-2022)
    Figure 70. Huitian Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2017-2022)
    Figure 71. Sinopharm ChuanKang Pharmaceutical Revenue Growth Rate in Organ Transplant Immunosuppreant Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed